After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for CVS Health Corporation (CVS) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $81.43. The CVS Health Corporation has recorded 969,027 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed CVS HEALTH REPORTS STRONG FOURTH QUARTER AND FULL-YEAR 2022 RESULTS.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Stocks Info
CVS Health Corporation is listed on the NYSE in the Healthcare sector while operating in the Healthcare Plans industry. At the end of the last regular session, the stock closed at $81.43 and fluctuated between $82.39 as its day high and $81.36 as its day low. The current market capitalization of CVS Health Corporation is $105.91B. A total of 10.09 million shares were traded on the day, compared to an average of 8.19M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, CVS has seen 2 BUY and 3 SELL insider trades, representing the acquisition of 137,466 and the disposition of 430,322 shares. Over the last 12 months, there were 40 BUYs and 37 SELLs from insiders. Insiders purchased 728,763 shares during that period but sold 1,253,263.
In the most recent transaction, Moriarty Thomas M sold 137,466 shares of CVS for 98.36 per share on Dec 15. After the transaction, the EVP & General Counsel now owns 608,129 company shares. In a previous transaction on Aug 04, Lotvin Alan sold 22,541 shares at 104.00 per share. CVS shares that EVP&President-PharmacyServices owns now total 109,183.
Among the insiders who sold shares, Lotvin Alan disposed of 120,899 shares on Aug 03 at a per-share price of $98.00. This resulted in the EVP&President-PharmacyServices holding 109,183 shares of CVS after the transaction. In another insider transaction, Finke Daniel P sold 9,546 shares at $100.00 per share on Aug 03. Company shares held by the EVP/Pres, Health Care Benefits now total 32,150.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. CVS Health Corporation pays an annual dividend of $2.42, resulting in a dividend yield of 2.97%, and it has a price to earnings (P/E) ratio of 26.09. CVS’s most recent ex-dividend date was 1/19/2023 when it declared a $0.6050 quarterly dividend that was paid in cash on 2/1/2023. Previously, the company paid the dividend on 11/1/2022 with an ex-dividend date of 10/20/2022. The CVS stock dividend was $0.55 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for CVS in the last 3 months, the mean price target is $112.17 with high estimates of $143.00 and low estimates of $95.00. In terms of 52-week highs and lows, CVS has a high of $109.69 and a low of $81.97.
As of this writing, CVS has an earnings estimate of $2.19 per share for the current quarter. EPS was calculated based on a consensus of 14 estimates, with a high estimate of $2.35 per share and a lower estimate of $1.99. The company reported an EPS of $2.09 in the last quarter, which was 5.00% higher than expectations of $1.99.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 23 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CVS is Sell with a score of 4.39. A total of 13 analysts rated the stock as Buy while 4 rated it as Overweight while 6 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.
